Publications

  1. Paranhos T, Katsumi Y, Brickhouse MJ, Eloyan A, Eckbo R, Zaitsev A, Du A, La Joie R, Thangarajah M, Taurone A  et al.  EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.  Neurology  2026 Oct 13;107(7):e218519. doi:10.1212/WNL.0000000000218519
  2. Iverson GL, Jamshidi P, Deep-Soboslay A, Hyde TM, Kleinman JE, Shepherd CE, Hazrati LN, Castellani RJ  Cortical subpial aging-related tau astrogliopathy in older adult men who participated in youth amateur American-style football.  J Neuropathol Exp Neurol  2026 Aug 01;85(8):868-880. doi:10.1093/jnen/nlag032
  3. Zhao J, Zhang M, Vidano C, Takarabe C, Bonakdarpour B  Musical Museum: an integrative approach to emotional, intellectual and social stimulation for individuals with Alzheimer's disease and related disorders and their caregivers.  Front Neurol  2026;17:1849901. pii:1849901
  4. Touroutoglou A, Katsumi Y, Hensel J, Schindler SE, Ibanez L, Brickhouse M, Eloyan A, Eckbo R, Zaitsev A, La Joie R  et al.  Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease.  Alzheimers Dement  2026 Jul;22(7):e71479. pii:e71479
  5. Umeres-Francia GE, Mejia-Bautista M, Jamshidi P, Ahrendsen JT  Ganglioglioma and gangliocytoma: a review for pathologists.  J Pathol Transl Med  2026 Jul;60(4):379-387. doi:10.4132/jptm.2026.06.06
  6. Stocks J, Barbieri E, Los MA, Thompson CK, Gefen T, Geula C, Mesulam MM, Weintraub S  Neuropathology-specific language features in primary progressive aphasia.  Alzheimers Dement  2026 Jul;22(7):e71633. pii:e71633
  7. Høilund-Carlsen PF, Alavi A, Andalib S, Castellani RJ, Costa T, de Girolamo G, Espay AJ, Neve RL, Perry G, Revheim ME  et al.  Serious side effects of Alzheimer's immunotherapy demand scrutiny.  Ageing Res Rev  2026 Jul;119:103151. doi:10.1016/j.arr.2026.103151
  8. Jategaonkar MS, Miller NH, Zur SE, Geula C, Penzes P, Zaccard CR  Nanotubular networks in the aging brain: from neuroprotection to neurodegeneration.  Front Hum Neurosci  2026;20:1864090. pii:1864090
  9. Kim KS, Zhang J, Arrieta VA, Dmello C, Grabis E, Yabo YA, Wang S, Habashy K, Duffy J, Zhao J  et al.  Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses.  Nat Commun  2026 Jun 25;17(1). pii:7968
  10. Rogalski E, Fegter O, Roberts AC, Bona M, Cummings E, Esparza M, Polley E, Rademaker A  Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial.  Alzheimers Dement (N Y)  2026;12(2):e70283. pii:e70283
  11. Sadleir KR, Gomez KP, Chandra S, Ley ML, Khatri AW, Guo J, Xue Y, Cepko CL, Vassar R  Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer's disease model mice.  Alzheimers Res Ther  2026 Jun 03;18(1). pii:184
  12. Mejia-Bautista M, Loxas M, Jamshidi P, Duckett D, Wolinsky JP, Ahrendsen JT  A 40-year-old woman with a spinal mass.  Brain Pathol  2026 Jun 01;:e70111. doi:10.1111/bpa.70111
  13. Minogue G, Zouridakis A, Nelson C, Kawles A, Keszycki R, Macomber A, Weintraub S, Gill N, Mao Q, Jamshidi P  et al.  Syndrome-specific vulnerability of neuronal and glial 4-repeat frontotemporal lobar degeneration-tau.  Brain  2026 Jun 01;. pii:awag190
  14. Friedman J, Jamshidi P, Huang W  Cushing disease and unilateral primary aldosteronism confounded by a nonfunctioning contralateral adrenal incidentaloma.  JCEM Case Rep  2026 Jun;4(6):luag114. pii:luag114
  15. Lin M, Chiotis K, Maiti P, Zhang J, Blazhenets G, Rocha S, Shankar R, Amuiri A, Hammers DB, Eloyan A  et al.  Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.  Brain Commun  2026;8(3):fcag176. pii:fcag176
  16. Hammers DB, Polsinelli A, Eloyan A, Taurone A, Thangarajah M, Foroud T, Gao S, Beckett L, La Joie R, Touroutoglou A  et al.  Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.  Alzheimers Dement (Amst)  2026;18(2):e70342. pii:e70342
  17. Hammers DB, Foster E, Eloyan A, Thangarajah M, Taurone A, Touroutoglou A, La Joie R, Beckett L, Gao S, Vemuri P  et al.  Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.  Alzheimers Dement  2026 May;22(5):e71492. pii:e71492
  18. Quiring ML, Edwards L, Bangen KJ, Ho EH, Carlsson CM, Galasko D, Weintraub S, Gershon R, Salmon DP  Effects of age and APOE ϵ4 genotype on the relationship between pulse pressure and executive function in older adults without dementia.  J Int Neuropsychol Soc  2026 May;32(4):301-310. doi:10.1017/S1355617726102008
  19. Wang H, Walenski M, Litcofsky K, Mack JE, Mesulam MM, Thompson CK  Online comprehension of verbal time reference in primary progressive aphasia: Evidence from eyetracking.  J Neurolinguistics  2026 May;78. pii:101318
  20. Dutt S, Leichter D, Cobigo Y, Wolf A, Kornak J, Clark A, Russell LL, Bouzigues A, Cash DM, Bocchetta M  et al.  Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling.  Ann Neurol  2026 May;99(5):1315-1326. doi:10.1002/ana.78167
  21. Split M, Kunicki ZJ, Ross D, Keszycki R, Prieto S, Manoochehri M, De Vito AN, Appleby B, Hales CM, Onyike C  et al.  Factors influencing accelerated progression in behavioral variant frontotemporal dementia.  J Neurol  2026 Apr 30;273(5). pii:297
  22. Wirtshafter HS, Mehta MR, Solla SA, Disterhoft JF  Hippocampal conditioning code dominates and disrupts the place code.  bioRxiv  2026 Apr 20;. pii:2026.02.17.706430
  23. Barbieri E, Kawles AS, Los M, Behn J, Geula C, Gefen T, Weintraub S, Mesulam MM  Atrophy progression in frontotemporal lobar degeneration-TDP-C with primary progressive aphasia.  Brain  2026 Apr 07;149(4):1194-1207. doi:10.1093/brain/awaf369
  24. Chan CK, Glover CM, Parker M, Grill JD, Langbaum JB, Morhardt DJ, Okonkwo O, Farrar-Edwards D, Wang S  Outreach, Recruitment and Engagement Cores of NIA-designated Alzheimer's Disease Research Centers: Current strategies and future directions.  Alzheimers Dement  2026 Apr;22(4):e71238. pii:e71238
  25. De Coster W, Van den Broeck M, Baker M, Ghayal NB, Wynants S, Batzler A, Pottier C, Alidadiani S, Küçükali F, Jenkins GD  et al.  A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.  Nat Genet  2026 Apr;58(4):726-736. doi:10.1038/s41588-026-02537-7
  26. Disouky A, Sanborn MA, Sabitha KR, Mostafa MM, Ayala IA, Bennett DA, Lu Y, Zhou Y, Keene CD, Weintraub S  et al.  Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's disease.  Nature  2026 Apr;652(8112):1264-1273. doi:10.1038/s41586-026-10169-4
  27. Alvarez FR, Nayman EI, Chen YH, Chen QC, Jamshidi P, Dixit K, Tariq H  Polymorphic central nervous system (CNS) immune deficiency/dysregulation-associated lymphoproliferative disorders show a uniquely aggressive clinicopathologic profile compared to their extra-CNS counterparts.  Hum Pathol  2026 Apr;170:106051. doi:10.1016/j.humpath.2026.106051
  28. Smith HL, Duckett DJ, Mejia-Bautista M, Alshawa A, Jamshidi P, Castellani RJ, Lukas RV, Chandler JP, Jennings LJ, Santana-Santos L  et al.  IDH-wildtype astrocytoma with FH mutation, epigenetic similarity to IDH-mutant astrocytoma, and hypermethylation of CDKN2A arising in the brainstem.  J Neuropathol Exp Neurol  2026 Apr 01;85(4):398-401. doi:10.1093/jnen/nlaf086
  29. Sadleir KR, Gomez KP, Chandra S, Ley ML, Khatri AW, Guo J, Xue Y, Cepko CL, Vassar R  Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer's disease model mice.  bioRxiv  2026 Mar 18;. pii:2026.03.16.711596
  30. Song R, Dapash M, Jamshidi P, Gondi V, Lukas RV, Khan OH  Survival and function in elderly patients with GBM: the role of surgical resection with contemporary multimodal therapy.  J Neurooncol  2026 Mar 17;177(2). pii:62
  31. Gutstein DB, Iorga M, Stocks J, Gill N, Sleeman J, Gefen TD, Los M, Nelson C, Geula C, Weintraub S  et al.  Identifying neuropathologic disease in primary progressive aphasia using narrative speech.  Alzheimers Dement  2026 Mar;22(3):e71294. pii:e71294
  32. George E, Braun M, Vassar R, Fox CK, Siegel DH, Mathes E, Frieden IJ, Hess CP, ,   Multi-center study of long-term evolution of neuroimaging findings in PHACE syndrome.  Eur J Paediatr Neurol  2026 Mar;61:1-7. doi:10.1016/j.ejpn.2026.02.004
  33. Salvo MA, Cuddy LK, Prokopenko D, Watkins E, Tanzi RE, Vassar R  Alzheimer's disease-linked ACE variants increase ACE1 catalytic activity and production of angiotensin II.  J Biol Chem  2026 Mar;302(3):111171. pii:111171
  34. Kawles A, Nelson C, Ayala I, Barbieri E, Castellani R, Geula C, Gefen T, Mesulam MM  Anatomical Progression of Neuropathology in FTLD-TDP Type C and Linkage to Annexin A11.  Ann Neurol  2026 Mar;99(3):639-655. doi:10.1002/ana.78095
  35. Coty-Fattal Z, Smith H, McCord M, Mejia-Bautista M, Dittman D, Primdahl D, Conway K, Becker N, Ahrendsen JT, Santana-Santos L  et al.  Rapid assessment of MGMT promoter methylation status by droplet digital polymerase chain reaction on intraoperative smear preparation: A proof-of-concept study.  J Neuropathol Exp Neurol  2026 Mar 01;85(3):280-284. doi:10.1093/jnen/nlaf122
  36. Bertholim-Nasciben L, Wang L, Xu W, Ramirez A, Moura S, Lu L, Liu X, Rajabli F, Celis K, Gearing M  et al.  Enhanced Hi-C Capture Analysis reveals complex regulatory architecture at the PICALM_EED locus for Alzheimer's disease.  bioRxiv  2026 Feb 17;. pii:2026.02.14.705927
  37. Youngblood MW, Tripathi S, Najem H, Congivaram H, Gomez M, Sears TK, Hurley L, Billingham LK, Silvers C, Wang W  et al.  STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.  Nat Commun  2026 Feb 12;17(1). pii:2685
  38. Rao NR, Santiago-Marrero I, DeGulis O, Nomura T, Goyal K, Lee S, Hark TJ, Dynes JC, Dexter EX, Dulewicz M  et al.  Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models.  Sci Transl Med  2026 Feb 11;18(836):eadp3984. doi:10.1126/scitranslmed.adp3984
  39. Macomber A, Zouridakis A, Lubbat V, Minogue G, Kawles A, Keszycki R, Nelson C, Gill N, Gutstein D, Castellani R  et al.  Vulnerability of anterior cingulate Von Economo neurons to FTLD-tauopathies in behavioral variant frontotemporal dementia.  Cereb Cortex  2026 Feb 09;36(2). pii:bhag011
  40. Dworak EM, Pila S, Novack MA, Hosseinian Z, Ho EH, Ece B, Karpouzian-Rogers T, Mather MA, Han YC, Bucko P  et al.  A scoping review of emotion and non-cognitive measures of decision-making ability in older adults by the ARMCADA study.  Front Public Health  2026;14:1718861. pii:1718861
  41. Hammers DB, Eloyan A, Thangarajah M, Taurone A, Gao S, Beckett L, Kirby K, Dage JL, Nudelman K, Aisen P  et al.  Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.  Alzheimers Dement  2026 Feb;22(2):e71160. pii:e71160
  42. Arrieta VA, Benotmane JK, Du R, Habashy KJ, Zhao J, Najem H, Wang S, Hou D, Katz JL, Vázquez-Cervantes GI  et al.  Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity.  Neuro Oncol  2026 Feb 01;28(2):440-453. doi:10.1093/neuonc/noaf213
  43. Castellani RJ, Bharadwaj RA, Fisher-Hubbard AO, Deep-Soboslay A, Hyde TM, Kleinman JE, Hazrati LN, Iverson GL  Hyperphosphorylated tau and amyloid-β proteinopathy in people over age 50: Findings from the Lieber Institute for Brain Development Brain Donation Repository.  J Alzheimers Dis  2026 Feb;109(4):1858-1873. doi:10.1177/13872877251411332
  44. Chiotis K, Blazhenets G, Soleimani-Meigooni DN, Aisen PS, Amuiri A, Atri A, Beckett L, Brickhouse M, Clark DG, Dage JL  et al.  Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.  medRxiv  2026 Jan 26;. pii:2026.01.25.26344738
  45. Petersen J, Gupta SV, Apple AC, Cobia D, Dokucu ME, Donnelly ED, Gradishar WJ, Mihailovic M, Reilly JL, Voss JL  et al.  Functional dysconnectivity in breast cancer patients undergoing hormone therapy.  J Clin Exp Neuropsychol  2026 Jan 21;:1-23. doi:10.1080/13803395.2026.2617353
  46. Salvi C, Luchini SA, Pestilli F, Hanekamp S, Parrish T, Beeman M, Grafman J  The white matter of Aha! moments.  BMC Psychol  2026 Jan 20;14(1):151. pii:151
  47. Chaubey K, Vázquez-Rosa E, Tripathi SJ, Shin MK, Yu Y, Dhar M, Chakraborty S, Yamakawa M, Wang X, Sridharan PS  et al.  Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brain.  Cell Rep Med  2026 Jan 20;7(1):102535. pii:102535
  48. Khan F, Petrosyan E, Liu Y, Bahrami A, Taefi E, Geula C, Lesniak MS, Chen P  Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis.  Cancer Res  2026 Jan 02;86(1):12-21. doi:10.1158/0008-5472.CAN-25-1791
  49. Kawles A, Zouridakis A, Nelson C, Keszycki R, Minogue G, Macomber A, Jamshidi P, Castellani RJ, Geula C, Gefen T  et al.  Dendritic location of dystrophic neurites in FTLD-TDP type C with annexinopathy.  Brain Pathol  2026 Jan;36(1):e70032. pii:e70032
  50. Mejia-Bautista M, Soto GS, Mitchell BI, Moravek MR, Conway K, Reyes I, Ahrendsen JT, Castellani RJ, Qi C, Jamshidi P  Disseminated BCGosis presenting as multiple intracranial lesions in an immunocompromised patient.  J Neuropathol Exp Neurol  2025 Dec 31;. pii:nlaf155

Follow Mesulam Institute on